{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:18:03Z","timestamp":1790741883744,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"am","delay-in-days":274,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006919","name":"Massachusetts Institute of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006919","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30EY014801"],"award-info":[{"award-number":["P30EY014801"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017024","name":"Salah Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002806","name":"Carl Zeiss Meditec AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002806","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006686","name":"University of Miami","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006686","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.ajo.2023.03.012","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:09:50Z","timestamp":1679443790000},"page":"11-22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"special_numbering":"C","title":["Onset and Progression of Persistent Choroidal Hypertransmission Defects in Intermediate Age-Related Macular Degeneration: A Novel Clinical Trial Endpoint"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2395-3536","authenticated-orcid":false,"given":"Jeremy","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengxi","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Laiginhas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gissel","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4127-4211","authenticated-orcid":false,"given":"Farhan","family":"Hiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Trivizki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia K.","family":"Waheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol Y.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Moult","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G.","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4068-6671","authenticated-orcid":false,"given":"Philip J.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajo.2023.03.012_bib0001","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0002","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ophtha.2012.10.036","article-title":"Clinical classification of age-related macular degeneration","volume":"120","author":"Ferris","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0003","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ophtha.2017.09.028","article-title":"Consensus definition for atrophy associated with age-related macular degeneration on OCT: classification of atrophy report 3","volume":"125","author":"Sadda","year":"2018","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2023.03.012_bib0004","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.oret.2020.12.009","article-title":"Imaging features associated with progression to geographic atrophy in age-related macular degeneration: classification of atrophy meeting report 5","volume":"5","author":"Jaffe","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3928\/23258160-20150422-03","article-title":"Comparison of geographic atrophy growth rates using different imaging modalities in the COMPLETE study","volume":"46","author":"Yehoshua","year":"2015","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"10.1016\/j.ajo.2023.03.012_bib0006","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ajo.2020.12.015","article-title":"Correlations between choriocapillaris and choroidal measurements and the growth of geographic atrophy using swept source OCT imaging","volume":"224","author":"Shi","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.03.012_bib0007","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.oret.2022.01.011","article-title":"Diagnosing persistent hypertransmission defects on en face OCT imaging of age-related macular degeneration","volume":"6","author":"Liu","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"8","key":"10.1016\/j.ajo.2023.03.012_bib0008","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.oret.2022.03.017","article-title":"Correlation between fundus autofluorescence and en face OCT measurements of geographic atrophy","volume":"6","author":"Velaga","year":"2022","journal-title":"Ophthalmol Retina"},{"key":"10.1016\/j.ajo.2023.03.012_bib0009","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ajo.2021.11.001","article-title":"Persistent hypertransmission defects detected on en face swept source optical computed tomography images predict the formation of geographic atrophy in age-related macular degeneration","volume":"237","author":"Laiginhas","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.10.4.11","article-title":"Validation of a novel automated algorithm to measure drusen volume and area using swept source optical coherence tomography angiography","volume":"10","author":"Jiang","year":"2021","journal-title":"Transl Vis Sci Technol"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100116","article-title":"Multimodal imaging, OCT B-scan localization, and en face OCT detection of macular hyperpigmentation in eyes with intermediate age-related macular degeneration","volume":"2","author":"Laiginhas","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.xops.2022.100162","article-title":"Multimodal imaging and en face OCT detection of calcified drusen in eyes with age-related macular degeneration","volume":"2","author":"Liu","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0013","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ophtha.2017.08.030","article-title":"Natural history of subclinical neovascularization in nonexudative age-related macular degeneration using swept-source OCT angiography","volume":"125","author":"de Oliveira Dias","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.03.012_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2019.06.017","article-title":"Two-year risk of exudation in eyes with nonexudative age-related macular degeneration and subclinical neovascularization detected with swept source optical coherence tomography angiography","volume":"208","author":"Yang","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.012_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.oret.2021.10.006","article-title":"Predicting the onset of exudation in treatment-naive eyes with nonexudative age-related macular degeneration","volume":"6","author":"Shen","year":"2022","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2023.03.012_bib0016","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.oret.2021.02.004","article-title":"Persistent hypertransmission defects on en face OCT imaging as a stand-alone precursor for the future formation of geographic atrophy","volume":"5","author":"Shi","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.012_bib0017","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ophtha.2019.09.035","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy in age-related macular degeneration: classification of atrophy meeting report 4","volume":"127","author":"Guymer","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2023.03.012_bib0018","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1364\/OL.35.001467","article-title":"Depth-resolved imaging of capillary networks in retina and choroid using ultrahigh sensitive optical microangiography","volume":"35","author":"Wang","year":"2010","journal-title":"Opt Lett"},{"issue":"10","key":"10.1016\/j.ajo.2023.03.012_bib0019","doi-asserted-by":"crossref","DOI":"10.1117\/1.JBO.20.10.100901","article-title":"Methods and algorithms for optical coherence tomography-based angiography: a review and comparison","volume":"20","author":"Zhang","year":"2015","journal-title":"J Biomed Opt"},{"key":"10.1016\/j.ajo.2023.03.012_bib0020","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajo.2021.10.032","article-title":"Optical coherence tomography measurements of the retinal pigment epithelium to Bruch membrane thickness around geographic atrophy correlate with growth","volume":"236","author":"Chu","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0021","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.ophtha.2010.08.018","article-title":"Progression of geographic atrophy in age-related macular degeneration imaged with spectral domain optical coherence tomography","volume":"118","author":"Yehoshua","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0022","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1159\/000510507","article-title":"Growth rate of geographic atrophy secondary to age-related macular degeneration: a meta-analysis of natural history studies and implications for designing future trials","volume":"64","author":"Wang","year":"2021","journal-title":"Ophthalmic Res"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.012_bib0023","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.ophtha.2016.09.012","article-title":"Incidence and growth of geographic atrophy during 5 years of comparison of age-related macular degeneration treatments trials","volume":"124","author":"Grunwald","year":"2017","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2023.03.012_bib0024","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1167\/tvst.7.6.40","article-title":"The rate of progression of geographic atrophy decreases with increasing baseline lesion size even after the square root transformation","volume":"7","author":"Mon\u00e9s","year":"2018","journal-title":"Transl Vis Sci Technol"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0025","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3928\/23258160-20130715-06","article-title":"Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina","volume":"44","author":"Nunes","year":"2013","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0026","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1167\/iovs.13-13199","article-title":"OCT minimum intensity as a predictor of geographic atrophy enlargement","volume":"55","author":"Stetson","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.ajo.2023.03.012_bib0027","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.ophtha.2019.12.009","article-title":"Natural history of geographic atrophy secondary to age-related macular degeneration: results from the prospective proxima A and B clinical trials","volume":"127","author":"Holekamp","year":"2020","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2023.03.012_bib0028","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.ophtha.2018.05.028","article-title":"Progression of geographic atrophy in age-related macular degeneration: AREDS2 report number 16","volume":"125","author":"Keenan","year":"2018","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.012_bib0029","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ophtha.2013.09.044","article-title":"Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study","volume":"121","author":"Yehoshua","year":"2014","journal-title":"Ophthalmology"},{"issue":"6","key":"10.1016\/j.ajo.2023.03.012_bib0030","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1001\/jamaophthalmol.2018.1544","article-title":"Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials","volume":"136","author":"Holz","year":"2018","journal-title":"JAMA Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.012_bib0031","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/IAE.0000000000002789","article-title":"Phase 2 study of the safety and efficacy of Brimonidine Drug Delivery System (BRIMO DDS) generation 1 in patients with geographic atrophy secondary to age-related macular degeneration","volume":"41","author":"Kuppermann","year":"2021","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0032","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 inhibitor pegcetacoplan for geographic atrophy secondary to age-related macular degeneration: a randomized phase 2 trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajo.2023.03.012_bib0033","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.oret.2020.03.019","article-title":"Orally administered alpha lipoic acid as a treatment for geographic atrophy: a randomized clinical trial","volume":"4","author":"Kim","year":"2020","journal-title":"Ophthalmol Retina"},{"issue":"12","key":"10.1016\/j.ajo.2023.03.012_bib0034","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1016\/j.ophtha.2014.06.034","article-title":"Optical coherence tomography-defined changes preceding the development of drusen-associated atrophy in age-related macular degeneration","volume":"121","author":"Wu","year":"2014","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ophtha.2022.09.004","article-title":"Incomplete retinal pigment epithelial and outer retinal atrophy: longitudinal evaluation in age-related macular degeneration","volume":"130","author":"Wu","year":"2023","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0036","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1167\/iovs.15-18572","article-title":"Drusen volume as a predictor of disease progression in patients with late age-related macular degeneration in the fellow eye","volume":"57","author":"Abdelfattah","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"10.1016\/j.ajo.2023.03.012_bib0037","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.ophtha.2019.05.016","article-title":"OCT risk factors for development of late age-related macular degeneration in the fellow eyes of patients enrolled in the HARBOR study","volume":"126","author":"Nassisi","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.012_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2015.09.016","article-title":"Drusen volume and retinal pigment epithelium abnormal thinning volume predict 2-year progression of age-related macular degeneration","volume":"123","author":"Folgar","year":"2016","journal-title":"Ophthalmology"},{"issue":"3","key":"10.1016\/j.ajo.2023.03.012_bib0039","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.oret.2022.09.007","article-title":"OCT risk factors for development of atrophy in eyes with intermediate age-related macular degeneration","volume":"7","author":"Hirabayashi","year":"2023","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajo.2023.03.012_bib0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3928\/23258160-20131217-01","article-title":"Change in drusen volume as a novel clinical trial endpoint for the study of complement inhibition in age-related macular degeneration","volume":"45","author":"Garcia Filho","year":"2014","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"issue":"2","key":"10.1016\/j.ajo.2023.03.012_bib0041","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.oret.2020.06.026","article-title":"Predicting progression of age-related macular degeneration using OCT and fundus photography","volume":"5","author":"Wu","year":"2021","journal-title":"Ophthalmol Retina"},{"issue":"4","key":"10.1016\/j.ajo.2023.03.012_bib0042","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2020.08.027","article-title":"C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial","volume":"128","author":"Jaffe","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2023.03.012_bib0043","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ajo.2016.11.002","article-title":"En face optical coherence tomography imaging for the detection of nascent geographic atrophy","volume":"174","author":"Schaal","year":"2017","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2023.03.012_bib0044","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.ophtha.2016.01.034","article-title":"Anatomic clinical trial endpoints for nonexudative age-related macular degeneration","volume":"123","author":"Schaal","year":"2016","journal-title":"Ophthalmology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939423001149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:45:04Z","timestamp":1762080304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939423001149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":44,"alternative-id":["S0002939423001149"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2023.03.012","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Onset and Progression of Persistent Choroidal Hypertransmission Defects in Intermediate Age-Related Macular Degeneration: A Novel Clinical Trial Endpoint","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2023.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}